Phoenix 1.5 Beta 8 ^NEW^
Development stretches back to the first Firefox 3 beta (under the codename 'Gran Paradiso') which had been released several months earlier on November 19, 2007, and was followed by several more beta releases in spring 2008 culminating in the June release. Firefox 3 had more than 8 million unique downloads the day it was released, setting a Guinness World Record.
Phoenix 1.5 Beta 8
Quality Amish-crafted top quality beta reins! Surely these will last you many years! Beta material can be quickly cleaned in a bucket of soapy water or dishwasher! Rust-free hardware! Colors: Black or Brown
I normally like FS, however, why was this even released ? I looked at your known issues page before downloading and this isnt a beta its an alpha. I wont consider it as it is, with the issues it has. Materials and 64bit just isnt worth all the (now) broken bits.
Looking at the change log, Firestirm 4.5.1 beta incorporates LL viewer changes up to 3.6.7. I ask as I think thw reallya nnotig problem of prims like floors and walls not showing until you click on them seems to be a new issue in the latest FS beta, whereas it was fixed (I think, at least reduced) in recent LL viewers. S yonee lae seeing this in FS 4.5.1 beta?
You might look at it this way: Running beta software and reporting problems through the channels is supporting FS and all the other users, a public service for the more civic minded. If you are just in it for you, stick with what works and stay safe.
I have had more people asking me for help with their phoenix viewer since the release of this beta version (4.5.1) than ever before with problems ranging from inability to view textures, avatars failing to rez in (including their own), inventory failing to load, and the list goes on.
In most cases I have been supportive of the actions of you and your team, but in this instance I cannot. This move to release a beta version through the main release channel has caused myself and my friends plenty of frustration, and it could all have been avoided by simply keeping this beta off the main release channel. Would have been fine to tell people about it, just the way it was done has caused some issues for some. In the future could we keep beta software out of the main update channel? That is all I ask.
I have been suddenly experiencing an issue since updating with Firestorm 4.2.2 and the beta version. It will not save my user name or password. This is the error message I get. How can I resolve this issue?
Over the course of Spring 2007, along with the chapter president Michael Binkley, the alumni began to teach the brothers about the chapter's history and what the chapter had accomplished only a few years prior. But more importantly, they reminded them how it had been done. With their help, the chapter began to open lines of communication with all the chapter alumni and moved toward establishing a stronger sense of purpose within the chapter itself. Held together through the efforts of Michael and his executive board, Beta Psi's turnaround was started with a very successful alumni picnic, with 30 alumni present after many years without much success in alumni events. At the end of that semester, with only a minimum of brothers, the chapter would elect one of its most important E-boards. As a sign of the change in the winds, the chapter voted at its last meeting of the spring to change the chapter mascot to the phoenix, the brilliant mythological firebird who after death, rises from its own ashes, born anew; a fitting symbol of what this chapter hoped to accomplish.
Led by the new president, Brittney Oliver, Beta Psi began a long journey toward rebuilding itself in the fall of 2008. The beginning of the semester was racked with difficulty as some brothers did not agree with the chapter being more active and having more stringent requirements, an all too familiar battle. However, the E-board persevered and interest in Phi Sigma Pi blossomed. The Alpha Beta class of initiates would show a promise not seen by Beta Psi for many months. Remarkably, despite several hiccups in the recruitment and initiation process, eleven new dedicated initiates resolved to become a part of our fraternity and showed an independent resolve to bond to each other in fellowship, knowing that they would be the new foundation for the chapter's endeavors. Having more than doubled their ranks, the chapter looked forward again with plans to expand every aspect of the brotherhood and its works in the community and on campus. After poor recruiting for years before, the chapter began to get their message out and found a large pool of interested students from every class and of every interest. Their excitement only grew as Spring 2009 saw Beta Psi's largest initiate class since 2002 join our ranks, swelling the chapter to its largest numbers in almost a decade. Remarkably, the new Alpha Gamma class showed more individual dedication to the fraternity than had been seen in many years. During their initiation, they displayed an energy and curiosity about the fraternity fitting of true scholars. Through the example of their big brothers and a united chapter, immediately they began to fill some of the most important offices of the chapter with all the faith and confidence of much older brothers, once again showing what a small group of dedicated brothers can accomplish when they share a common purpose. From struggling with only 8 brothers just a year before, the chapter had grown to over 30 brothers, eager to learn where this new impetus could take them. Just like the phoenix they chose to represent them, the chapter was set not only to return to its former accomplishments, but to reach beyond its history and take a place amongst the all-time best chapters of Phi Sigma Pi.
The original chapter mascot was the purple panther, chosen for its color and alliteration. As of spring 2008, the official mascot was changed to the phoenix, symbolizing the rebirth of the Beta Psi chapter from its lowest point during the Fall of 2007. Our current version of the mascot was designed and created by alumnus Michael Binkley and made official in April 2009.
Phoenix Sim is also still online! Ballie from Netherlands has grabbed the phoenix-sim-online.com domain and is hosting a server! More info here. So the native online flying is again possible, enjoy Phoenix with friends again!
Extended-spectrum beta-lactamases (ESBL), produced by Enterobacteriaceae members are enzymes that especially cause a resistance to cephalosporin group antibiotics commonly used in clinics. Early and rapid detection of ESBL production is crucial for antimicrobial treatment and infection control; however the methods used for this purpose are time consuming (24 to 48 hours). The aim of this study was to determine a flow cytometry based-test which provides to detect ESBL producing bacteria in a short time. A total of 38 ESBL-producing (29 Escherichia coli, 9 Klebsiella pneumoniae) and 10 non-producing (5 E.coli, 5 K.pneumoniae) Enterobacteriaceae strains isolated between 2012 and 2013 were included in this study. The identification and antibiotic susceptibility tests of the isolates were performed by using Phoenix(TM) 100 automated system (Becton Dickinson, USA). The presence of bla(TEM), bla(SHV), bla(CTX-M1), bla(CTX-M2) and bla(CTX-M9) genes were investigated in ESBL positive isolates via polymerase chain reaction method. At least one of the ESBL genes were detected in 36 out of 38 isolates and no genes were detected in two E.coli isolates. In flow cytometric method, the percentages of death cells exposed to cephalosporin [(ceftazidime (CAZ) or cefotaxime (CTX)] and clavulanic acid (CLA) combination, were compared with death cells exposed only to cephalosporin (CAZ or CTX). CLA index values (CAZ-CLA and CTX-CLA indices) were obtained for CTX and CAZ. Index values which was higher than 1.5 just for one cephalosporin were accepted as GSBL positive. The mean index values for CTX-CLA in ESBL positive strains according to their genotypic characteristics were between 1.14 and 7.22, while those values for CAZ-CLA were between 0.85 and 5.6. When the two groups of 38 ESBL positive and 10 ESBL negative strains were evaluated, statistically significant difference was detected for both CAZ-CLA and CTX-CLA indices (p
Layout table for study information Study Type : Interventional (Clinical Trial) ActualEnrollment : 78 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Treatment Official Title: A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta Actual Study Start Date : June 2016 Actual Primary Completion Date : October 2021 Actual Study Completion Date : July 2022 Resource links provided by the National Library of Medicine MedlinePlus Genetics related topics: Fabry disease MedlinePlus related topics: Kidney Tests Genetic and Rare Diseases Information Center resources: Fabry Disease Sphingolipidosis U.S. FDA Resources Arms and Interventions Go to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Arm Intervention/treatment Experimental: PRX-102 (pegunigalsidase alfa)PRX-102 infusion every 2 weeks Biological: PRX-102 (pegunigalsidase alfa)PRX-102 1 mg/kg every 2 weeksOther Names:pegunigalsidase alfa
Recombinant human alpha galactosidase-A
Active Comparator: agalsidase betaagalsidase beta infusion every 2 weeks Biological: agalsidase betaagalsidase beta 1 mg/kg every 2 weeksOther Name: Fabrazyme Outcome Measures Go to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Primary Outcome Measures : eGFR Slope [ Time Frame: Every month for 2 years ]eGFR Slope Secondary Outcome Measures : Left Ventricular Mass Index (g/m2) by MRI [ Time Frame: Every 12 months for 2 years ] Plasma Lyso-Gb3 [ Time Frame: 1.5 month, every 3 months for 1 year and then every 6 months up to 24 months ] Plasma Gb3 [ Time Frame: 1.5 month, every 3 months for 1 year and then every 6 months up to 24 months ] Urine Lyso-GB3 [ Time Frame: 1.5 month, every 3 months for 1 year and then every 6 months up to 24 months ] Protein/creatinine ratio [ Time Frame: Every 3 months for 2 years ] Frequency of pain medication use [ Time Frame: Every 2 weeks for 2 years ] Exercise tolerance (Stress Test) [ Time Frame: Every year for 2 years ] Short Form Brief Pain Inventory (BPI) [ Time Frame: Every 6 months for 2 years ] Mainz Severity Score Index (MSSI) [ Time Frame: Every 6 months for 2 years ] Quality of life EQ-5D-5L [ Time Frame: Every 6 months for 2 years ] Other Outcome Measures: PRX-102 pharmacokinetics [ Time Frame: Day 1, 6 months, 12 months and 24 months ]PRX-102 pharmacokinetics parameters Anti-drug IgG antibodies [ Time Frame: Every 2 weeks for 1 month, then every month for the first 6 months and every 3 month up to 24 months ] Eligibility CriteriaGo to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. Layout table for eligibility information Ages Eligible for Study: 18 Years to 60 Years (Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: